Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 7/20 | 0.44 |
| ▸ | JAK2 | O60674 | 5/20 | 0.44 |
| ▸ | JAK1 | P23458 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6538070 | 0.87 | KMT2A (0.43) | TYK2JAK2JAK1GAAMAPT | |
| SCHEMBL6537664 | 0.82 | POLB (0.45) | TYK2JAK2JAK1GAAMAPT | |
| SCHEMBL6537386 | 0.80 | MAPT (0.51) | TYK2JAK2JAK1GAAMAPT | |
| SCHEMBL6537800 | 0.80 | TYK2 (0.46) | TYK2JAK2JAK1GAAMAPT | |
| SCHEMBL6537948 | 0.80 | MAPT (0.44) | MAPTKMT2AMEN1POLBSMN1; SMN2 | |
| SCHEMBL6538084 | 0.80 | TYK2 (0.53) | TYK2JAK2JAK1MAPTKMT2A | |
| SCHEMBL6538321 | 0.79 | MAPT (0.45) | TYK2JAK2JAK1GAAMAPT | |
| SCHEMBL6538318 | 0.79 | MAPT (0.45) | TYK2JAK2JAK1GAAMAPT | |
| SCHEMBL6538033 | 0.79 | MAPT (0.39) | TYK2JAK2JAK1GAAMAPT | |
| SCHEMBL6538073 | 0.78 | TYK2 (0.56) | TYK2JAK2JAK1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0876345-B1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-08-18 | — | — | EP | disclosed |
| US-6008230-A | TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-12-28 | — | — | US | disclosed |